SMG SCOTTS MIRACLE-GRO CO
Agricultural Chemicals · NYSE · SEC CIK 825542 · Fiscal year ends 09/30
Financial factors as of 2026-06-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.3%
TTM net income YoY—
TTM EPS YoY48.8%
Revenue 3-yr CAGR-2.8%
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin11.8%
Net margin2.2%
FCF margin7.8%
EBITDA margin13.7%
Returns
ROE—
ROA2.4%
ROIC (approx.)12.5%
Asset turnover1.08x
Leverage & solvency
Liabilities / assets106.6%
Debt / equity—
Current ratio1.21x
Interest coverage3.53x
Cash quality & payout
Operating cash flow / net income5.00x
Accruals ratio-9.4%
Payout ratio208.9%
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $3.41B | $3.55B |
| Cost of revenue | $2.35B | $2.62B |
| Gross profit | $1.04B | $850.50M |
| R&D expense | $34.80M | $34.60M |
| SG&A expense | $603.40M | $559.00M |
| Operating income | $358.60M | $208.80M |
| Interest expense | $128.80M | $158.80M |
| Pretax income | $221.70M | -$23.60M |
| Income tax | $76.50M | $11.30M |
| Net income | $145.20M | -$34.90M |
| EBITDA | $421.30M | $273.70M |
| EPS (basic) | 2.52 | -0.61 |
| EPS (diluted) | 2.47 | -0.61 |
| Dividends declared per share | 2.64 | 2.64 |
| Weighted avg. shares (diluted) | 58.70M | 56.80M |
| Balance sheet | ||
| Cash & equivalents | $32.80M | $71.60M |
| Receivables | $160.80M | $176.80M |
| Inventory | $542.70M | $587.50M |
| Current assets | $940.30M | $980.40M |
| PP&E, net | $607.60M | $609.50M |
| Goodwill | $243.90M | $243.90M |
| Intangibles | $352.00M | $418.80M |
| Total assets | $2.74B | $2.87B |
| Current liabilities | $739.70M | $750.30M |
| Short-term debt | $57.20M | $52.60M |
| Long-term debt | $2.05B | $2.17B |
| Total debt | $2.11B | $2.23B |
| Total liabilities | $3.10B | $3.26B |
| Shareholders' equity | -$357.50M | -$390.60M |
| Net debt | $2.07B | $2.16B |
| Shares outstanding | 57.80M | 57.10M |
| Cash flow statement | ||
| Operating cash flow | $371.30M | $667.50M |
| Capital expenditure | $97.40M | $84.00M |
| Free cash flow | $273.90M | $583.50M |
| Investing cash flow | -$112.10M | -$100.40M |
| Financing cash flow | -$294.00M | -$527.90M |
| Depreciation & amortization | $62.70M | $64.90M |
| Stock-based compensation | $69.00M | $80.40M |
| Dividends paid | $154.30M | $151.30M |
| Share buybacks | $18.40M | $5.10M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.